Scientific Advisors

Robert Siliciano, M.D., Ph.D., Chairman of CETF SAB

Johns Hopkins University

Dr. Robert Siliciano is a Professor of Medicine at the John Hopkins University School of Medicine and an investigator with the Howard Hughes Medical Institute. He studies HIV, specifically viral reservoirs that prevent curing HIV infection and better understanding how the T-cell reservoir is established and maintained. His research interests are in drug therapy for HIV infection.

His laboratory work is in basic pharmacodynamics principles that explain how antiretroviral drugs work. His team has uncovered a previously unrecognized form of intermolecular cooperatively that explains why certain classes of antiretroviral drugs are so effective at inhibiting viral replication.

He attended Princeton University and the John Hopkins University School of Medicine and has received much recognition including the Doris Duke Charitable Foundation Distinguished Clinical Scientist award.

Donate to the
COVID-19 Early Treatment Fund today